Court filings show pharmaceutical giant Johnson & Johnson has agreed to pay $7.8 million to settle a lawsuit over how the company marketed an antipsychotic drug to Arkansas doctors.
The Arkansas Democrat-Gazette reports $2 million will go to a Texas law firm that represented Arkansas in the suit, which began more than seven years ago.
A Pulaski County jury ruled three years ago that the New Jersey-based company, through its Janssen Pharmaceutical subsidiary, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was imposed on Johnson & Johnson, but it was later overturned by the Arkansas Supreme Court.
Breaking news and the stories that matter to your neighborhood.
Janssen representative Michelle Bauer said Monday that the settlement isn't an admission of liability.